Siemens completes acquisition of GSD

SIEMENSFollowing the announcement in January 2007 of its intent, Siemens Medical Solutions announced today that it has received antitrust approval and completed its acquisition of Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD), headquartered in Berlin. The new entity, Siemens Medical Solutions GSD GmbH, will remain a separate legal entity, operating as a wholly owned subsidiary of Siemens Medical Solutions as part of the Health Services (HS) Division. With this acquisition Siemens strengthens its position in the European healthcare IT market.

With more than 300 customers in 14 countries, GSD is a leading health information systems (HIS) company. With the addition of GSD's i.s.h.med and i.c.m.health product lines, the move enhances Siemens' global healthcare IT portfolio and infuses additional industry expertise into its product and service offerings for the European market. GSD generated a revenue of 23.6 million EUR and employed 167 people in fiscal year 2006 (ended December 31).

"We are pleased to officially welcome the talent and resources of GSD into our trendsetting healthcare IT portfolio," said Erich R. Reinhardt, member of the Managing Board of Siemens AG, and President and CEO of Siemens Medical Solutions. "As with our continued investments in our Soarian healthcare process management solution, which is distinguished by its unique architecture and workflow engine, and with the internationally successful health information system, i.s.h.med, we see tremendous potential for best practice sharing and optimized service and support for our customers through this investment in GSD."

The combined product portfolio is unique in its regional and functional market coverage, enabling Siemens to tailor its solution offerings for customers at various levels of IT sophistication and maturity.

"We remain steadfast in our commitment to improving the quality and reducing the cost of healthcare through IT, which has become an essential component of our global strategy as we move toward more personalized medicine," Reinhardt added. "Today, we are taking an important step in improving our market position in Germany and expanding our presence in Europe. Additionally, we have high expectations that the combined business expertise and industry knowledge of the HS and GSD teams will ensure that our product and service innovation continues, our customers are well-positioned to achieve their desired outcomes, and that we are successful in all markets we serve."

After the formation of Siemens Medical Solutions Diagnostics, following the acquisitions of Diagnostic Products Corporation (DPC) and Bayer Diagnostics, the acquisition of GSD is Siemens Medical Solutions' third acquisition in the past three quarters. These moves support Siemens' strategy of building the industry's first full service diagnostics company that combines diagnostic imaging, laboratory diagnostics and clinical information technology under one roof along the value chain.

Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD) is one of Europe's leading manufacturers and service providers of IT solutions for hospitals. Its circle of users comprises over 268 hospitals and hospital operators around the world and GSD provided support for over 54 hospitals in different SAP projects. For the past 25 years GSD's has been providing the healthcare sector with all the IT solutions required to run a modern hospital: from software development to hardware solutions, over planning, support and implementation of networks, to the complete outsourcing of system operations. The company generated a revenue of 23.6 million Euro and employed 167 people in the fiscal year 2006 (ended December 31). Further information at www.gsd.de

Siemens AG (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements. Siemens provides innovative technologies and comprehensive know-how to benefit customers in over 190 countries. Founded more than 155 years ago, the company focuses on the areas of Information and Communications, Automation and Control, Power, Transportation, Medical, and Lighting. In fiscal 2006 (ended September 30), Siemens had sales from continuing operations of EUR 87.3 billion and net income of EUR 3.033 billion, according to U.S. GAAP. Further information is available on the Internet at: www.siemens.com

Siemens Medical Solutions of Siemens AG (NYSE:SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting www.siemens.com/medical

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...